Quantum Genomics (Alternext – FR0011648971 – ALQGC), a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, has published information on the total number of voting rights and number of shares comprising the share capital on august 23rd 2015, in accordance with the provisions of article 223-16.
[button link=”http://www.quantum-genomics.com/www/wp-content/uploads/2015/08/QGC_shares-voting-rights_20150824_UK-VF.pdf” target=”_blank” title=”Download Press Release” size=”small” color=”red”]
